Cargando…
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
Inflammation is implicated in the development and severity of the coronavirus disease 2019 (COVID-19), as well as in the pathophysiology of diabetes. Diabetes, especially when uncontrolled, is also recognized as an important risk factor for COVID-19 morbidity and mortality. Furthermore, certain infl...
Autores principales: | Katsiki, Niki, Ferrannini, Ele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448766/ https://www.ncbi.nlm.nih.gov/pubmed/32900588 http://dx.doi.org/10.1016/j.jdiacomp.2020.107723 |
Ejemplares similares
-
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2011) -
Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
por: Katsiki, Niki, et al.
Publicado: (2020) -
Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia
por: Kolovou, Genovefa, et al.
Publicado: (2022) -
Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023) -
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery
por: Daniele, Giuseppe, et al.
Publicado: (2020)